ResearcherOkayama UniversityNo recent work listed
Shuya Yano
Matched on OpenAlex author ID A5062335013. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2013: 2 papers · 2014: 5 papers · 2015: 1 paper
Papers 8
- Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-… Co-author DOI 10.1038/cgt.2015.26↗
- Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). Co-author DOI 10.1002/jcb.24769↗
- Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. Co-author DOI 10.1002/jcb.24837↗
- Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models. Co-author DOI 10.1371/journal.pone.0099977↗
- The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. Co-author DOI 10.1371/journal.pone.0103382↗
- Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenogra… Co-author DOI 10.18632/oncotarget.2641↗
- Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Co-author DOI 10.4161/cc.25872↗
- Single cell time-lapse imaging of focus formation by the DNA damage-response protein 53BP1 after UVC irradiation of human pancreatic cancer cells. Co-author PMID 23564775↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Bouvet · 8 shared papers, 2013–2015 · strength 0.28
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. DOI 10.1002/jcb.24837↗
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Yukihiko Hiroshima · 8 shared papers, 2013–2015 · strength 0.28
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. DOI 10.1002/jcb.24837↗
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Robert M. Hoffman · 8 shared papers, 2013–2015 · strength 0.28
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. DOI 10.1002/jcb.24837↗
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Shinji Miwa · 7 shared papers, 2013–2014 · strength 0.24
- Paper Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. DOI 10.1002/jcb.24837↗
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Ali A. Maawy · 6 shared papers, 2013–2015 · strength 0.21
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Fuminari Uehara · 6 shared papers, 2013–2014 · strength 0.21
- Paper Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. DOI 10.1002/jcb.24837↗
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Itaru Endo · 5 shared papers, 2013–2014 · strength 0.17
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Atsushi Suetsugu · 3 shared papers, 2013–2015 · strength 0.11
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Paper Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cance… DOI 10.4161/cc.25872↗
- Takashi Murakami · 3 shared papers, 2014 · strength 0.10
- Paper Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic … DOI 10.1371/journal.pone.0099977↗
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Paper Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic c… DOI 10.18632/oncotarget.2641↗
- Matthew H. G. Katz · 2 shared papers, 2014–2015 · strength 0.08
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Jason B. Fleming · 2 shared papers, 2014–2015 · strength 0.08
- Paper Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of … DOI 10.1038/cgt.2015.26↗
- Paper Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft… DOI 10.1002/jcb.24769↗
- Yasushi Ichikawa · 2 shared papers, 2014 · strength 0.07
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Paper Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic c… DOI 10.18632/oncotarget.2641↗
- Mohamed K. Hassanein · 2 shared papers, 2013–2014 · strength 0.06
- Paper The tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid. DOI 10.1371/journal.pone.0103382↗
- Paper Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cance… DOI 10.4161/cc.25872↗
- Michihiro Yamamoto · 1 shared paper, 2015 · strength 0.04
- Rhiana S. Menen · 1 shared paper, 2014 · strength 0.03
- Ryutaro Mori · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.